New technology associated with gene therapy and stem cell research is driving the orthopedic biomaterials market, which represents 14 percent of the global orthopedics market, according to a report from Kalorama Information.
The orthopedic biomaterials market represented $5.8 billion worldwide and is projected to experienced double digit annual growth through 2016. Growth factor-based graft substitutes, such as recombinant bone morphogenic proteins, and cell-based bone graft substitutes, such as those containing mesenchymal stem cells, have been the fastest-growing areas over the past few years.
As the field has become more competitive, bigger companies such as Stryker, Johnson and Johnson, Wright Medical and Zimmer Holdings have become interested in the orthopedic biomaterials market.
Read the report on orthopedic biomaterials.
Related Articles on Orthopedic Devices:
Staying Competitive in the Orthopedic Device Market: Q&A With Stryker Orthopaedics
Orthopedic Device Company CEOs Expect Market Growth in 2011
Global Orthopedic Instrumentation Market to Exceed $475B by 2015
The orthopedic biomaterials market represented $5.8 billion worldwide and is projected to experienced double digit annual growth through 2016. Growth factor-based graft substitutes, such as recombinant bone morphogenic proteins, and cell-based bone graft substitutes, such as those containing mesenchymal stem cells, have been the fastest-growing areas over the past few years.
As the field has become more competitive, bigger companies such as Stryker, Johnson and Johnson, Wright Medical and Zimmer Holdings have become interested in the orthopedic biomaterials market.
Read the report on orthopedic biomaterials.
Related Articles on Orthopedic Devices:
Staying Competitive in the Orthopedic Device Market: Q&A With Stryker Orthopaedics
Orthopedic Device Company CEOs Expect Market Growth in 2011
Global Orthopedic Instrumentation Market to Exceed $475B by 2015